Update on the emerging role of telavancin in hospital-acquired infections
Obinna N Nnedu,1 George A Pankey2 1Infectious Disease Department, Ochsner Clinic Foundation, New Orleans, LA, USA; 2Infectious Disease Research, Ochsner Clinic Foundation, New Orleans, LA, USA Abstract: Telavancin is a lipoglycopeptide that has activity against gram-positive aerobic and anaerobic...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-04-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Online Access: | http://www.dovepress.com/update-on-the-emerging-role-of-telavancin-in-hospital-acquired-infecti-peer-reviewed-article-TCRM |